Generation and evaluation of an IPTG-regulated version of Vav-gene promoter for mouse transgenesis

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Grespi, Francesca ^a   Ottina, Eleonora ^a   Yannoutsos, Nikolaos ^a   Geley, Stephan ^a   Villunger, Andreas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROPYL THIOGALACTOSIDE; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; VENUS PROTEIN; DNA; VAV PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL IDENTIFICATION; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; GENE REPRESSION; GENE SILENCING; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LACTOSE OPERON; MOUSE; NONHUMAN; PROCESS OPTIMIZATION; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERTANT; TRANSGENE; TRANSGENIC MOUSE; TRANSGENICS; VAV GENE; ANIMAL; DRUG EFFECT; GENETICS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

MAMMALIA; MUS; VERTEBRATA;

ANIMALS; BASE SEQUENCE; DNA; GENE EXPRESSION REGULATION; ISOPROPYL THIOGALACTOSIDE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-VAV;

EID: 79952829909     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018051     Document Type: Article

References (21)

1. Adams JM, Harris AW, Strasser A, Ogilvy S, Cory S, (1999) Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector. Oncogene 18: 5268-5277.
2. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, et al. (1996) Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A 93: 10933-10938.
3. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, et al. (1999) Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 27: 4324-4327.
4. Gama Sosa MA, De Gasperi R, Elder GA, (2010) Animal transgenesis: an overview. Brain Struct Funct 214: 91-109.
5. Corbel SY, Rossi FM, (2002) Latest developments and in vivo use of the Tet system: ex vivo and in vivo delivery of tetracycline-regulated genes. Curr Opin Biotechnol 13: 448-452.
6. Ogilvy S, Metcalf D, Gibson L, Bath ML, Harris AW, et al. (1999) Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood 94: 1855-1863.
7. Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW, et al. (1999) Constitutive bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proceedings of the National Academy of Sciences of the United States of America 96: 14943-14948.
8. Campbell KJ, Bath ML, Turner ML, Vandenberg CJ, Bouillet P, et al. (2010) Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells and enhances drug-resistance. Blood.
9. Georgiades P, Ogilvy S, Duval H, Licence DR, Charnock-Jones DS, et al. (2002) VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages. Genesis 34: 251-256.
10. Cronin CA, Gluba W, Scrable H, (2001) The lac operator-repressor system is functional in the mouse. Genes Dev 15: 1506-1517.
11. Scrable H, (2002) Say when: reversible control of gene expression in the mouse by lac. Semin Cell Dev Biol 13: 109-119.
12. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, et al. (2002) A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 20: 87-90.
13. Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ, (1999) Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun 260: 712-717.
14. Huang WY, Aramburu J, Douglas PS, Izumo S, (2000) Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat Med 6: 482-483.
15. Ryan A, Scrable H, (2004) Visualization of the dynamics of gene expression in the living mouse. Mol Imaging 3: 33-42.
16. Figge J, Wright C, Collins CJ, Roberts TM, Livingston DM, (1988) Stringent regulation of stably integrated chloramphenicol acetyl transferase genes by E. coli lac repressor in monkey cells. Cell 52: 713-722.
17. Williams A, Harker N, Ktistaki E, Veiga-Fernandes H, Roderick K, et al. (2008) Position effect variegation and imprinting of transgenes in lymphocytes. Nucleic Acids Res 36: 2320-2329.
18. Ogilvy S, Elefanty AG, Visvader J, Bath ML, Harris AW, et al. (1998) Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. Blood 91: 419-430.
19. Scrable H, Stambrook PJ, (1997) Activation of the lac repressor in the transgenic mouse. Genetics 147: 297-304.
20. Robertson A, Perea J, Tolmachova T, Thomas PK, Huxley C, (2002) Effects of mouse strain, position of integration and tetracycline analogue on the tetracycline conditional system in transgenic mice. Gene 282: 65-74.
21. Wyborski DL, Short JM, (1991) Analysis of inducers of the E.coli lac repressor system in mammalian cells and whole animals. Nucleic Acids Res 19: 4647-4653.